MedTrace Logo

Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors

NCT03131440 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2023-03-10

Study results available
· View outcomes & findings →

Summary

The overall objective of the proposed research is to pilot test the feasibility and acceptability of a set of more scalable technology-supported physical activity promotion intervention strategies in breast cancer survivors using tMultiphase Optimization Strategy Trial (MOST) methodology. MOST involves highly efficient randomized experimentation to assess the effects of individual intervention strategies, and thereby identify which strategies and what strategy levels make the important contributions to the overall program's effect on physical activity. This information then guides assembly of an optimized physical activity program, that achieves target outcomes with least resource consumption and participant burden. The resulting intervention will have great potential for scalability because it uses technology (smartphones) participants already own and requires no on-site visits.

Conditions

  • Breast Cancer Female
  • Physical Activity

Interventions

BEHAVIORAL

Core

The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.

BEHAVIORAL

Support Calls

Participants will receive 6 bi-weekly phone calls from study staff.

BEHAVIORAL

App+

Participants will receive "deluxe" version of smartphone app with additional features.

BEHAVIORAL

Online gym

Participants will receive access to online exercise videos.

BEHAVIORAL

App notifications

Participants will receive motivational app notifications

BEHAVIORAL

Buddy

Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2019-06-17
Completion
2019-06-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03131440 on ClinicalTrials.gov